FIP is launching a transforming vaccination globally and regionally 24 part series. In series 1, we are running 8 episodes that focus on identifying the needs for vaccine transformation across science, practice and workforce and education. In the last event of the series today, part 8, the moderators from each panel presentation share their key summaries and insights gathered in the field of science, practice, workforce and education to transform vaccinations globally and regionally.

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Moderators:
Dominique Jordan, FIP President - Switzerland
Catherine Duggan, FIP CEO - the Netherlands

Panellists:
1. Ema Paulino, FIP Professional Secretary - Portugal
2. Paul Sinclair, Community Pharmacist Chair Board of Pharmaceutical Practice - Australia
3. Giovanni Pauletti, FIP Scientific Secretary - USA
4. Ross MacKinnon, Chair of FIP Board of Pharmaceutical Science, FIP - Australia
5. Ralph Altiere, Chair of FIP Education FIP - USA
6. Ian Bates, Chair of pharmacy education, UCL - UK

La Organización Mundial de la Salud ha considerado la reticencia a la vacunación o la negativa a vacunarse a pesar de la disponibilidad de vacunas, como uno de los diez asuntos globales que requiere de la máxima atención, ya que amenaza con revertir los progresos realizados en la lucha contra las enfermedades prevenibles por vacunación. En este webinar se abordarán el concepto, las causas y las consecuencias de este fenómeno y se establecerá el importante rol del farmacéutico como educador en temas de inmunización, dada la facilidad de acceso y la confianza que tienen los pacientes y la comunidad en este profesional sanitario.

1) Distinguir el concepto de reticencia a la vacunación.

2) Reconocer las actuaciones de los movimientos antivacunas y como afectan la vacunación.

3) Determinar el papel clave del farmacéutico como educador en vacunación.

Event chair: Yajaira Quesada Rojas, Secretaria Técnica, Foro Farmacéutico de las Américas

Panelistos: Eduardo Savio Quevedo, Presidente de Foro Farmacéutico de las Américas - Uruguay Nuria Montero Chinchilla, Directora de Práctica Farmacéutica, Foro Farmacéutico de las Américas - Costa Rica Roberto Debagg, Médico pediatra infectólogo - Argentina

Join part two of our three-part webinar series on the Global Immunisation Agenda: Advocating for Life Course Immunisation on November 12, 2020 at 15:30 – 17:00 CEST to discuss the urgency, relevance and need for collective advocacy toward public health action, particularly to support vulnerable and at-risk populations given the backdrop of the current pandemic.

This webinar, Advocating for Life Course Immunisation, will discuss the impact of infectious diseases on older age groups and at-risk populations along with the need to expand and diversify vaccination gateways for adults.

Set against the backdrop of the current pandemic as well as the expected launch of the timely and much needed intersecting intergovernmental plans of action; namely the WHO Decade of Healthy Ageing (2020-2030), the new WHO Global Vaccine Action Plan (GVAP) and the WHO Immunisation Agenda 2030: A Global Strategy¹, delivering on a life course approach to immunisation has never been so important.

Please join us for this important discussion with a panel of experts from leading organisations:

• Dr Michael Moore PhD, Past President, World Federation of Public Health Associations, Distinguished Fellow, The George Institute for Global Health, Adjunct Professor, University of Canberra and District Governor, Rotary International
• Dr Justin Ortiz MD, Associate Professor of Medicine, University of Maryland
• Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation
• David Sinclair, Director, International Longevity Centre UK
• Dr Jane Barratt PhD, Secretary General, International Federation on Ageing

The 3^rd edition of Phar-East is happening in Singapore from 31 March to 1 April 2020. It is your chance to network with over 1,000 leading experts from across Asia and gain insights about the latest trends in the pharma and biotech industry. The conference will feature 5 premium theatres focusing on immunotherapy, regulatory affairs, Pharma 4.0, market access, biotech investments, clinical trials and an all-new track – Bio Data. Running alongside the conference, will be an all-new innovation and start-up zone, where we will be bringing in more than 80 start-ups in the pharma and biotech industry to share their latest technologies and solutions. Get the latest updates here or download the event brochure here

Join us at Asia’s Pharma & Biotech Festival and be a part of Asia’s fastest growing pharmaceutical and biotech market! Book your tickets now

The LLLP conferences bring together international and national colleagues with interest and research to share in the area of pharmacy education and professional development. The conference facilitates participant access to high quality educational programs, internationally significant research and development, and world-renowned leaders in the field.

A Forum on Human Resources for Health Supply Chain Management.

https://ptdevents.org.za/

Come to the 2020 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.